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Abstract Rana catesbeiana ribonuclease (RC-RNase) exerted
strong anti-tumor activity and its cytotoxicity was shown to
correlate with di¡erentiation stages of three di¡erent hepatoma
cell lines. In this study, we demonstrate di¡erent RC-RNase
cytotoxicity in undi¡erentiated HL-60 cells and in those that
had been induced to di¡erentiate by retinoic acid or dimethyl-
sulfoxide. RC-RNase showed cytotoxicity in undi¡erentiated
HL-60 cells, but not in HL-60 cells undergoing terminal di¡er-
entiation. Furthermore, the caspase-9/caspase-3 pathway was
activated when RC-RNase induced death in undi¡erentiated
HL-60 cells and induction of di¡erentiation led to a reversal
of the caspase activation pathway.
* 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Ribonuclease from Rana catesbeiana (RC-RNase) and on-
conase from Rana pipiens are cytotoxic ribonucleases ex-
tracted from frog oocytes and have been proposed to be
anti-tumor reagents [1^5]. In addition to having 48.2% amino
acid sequence homology, both RC-RNase and onconase con-
tain a lectin domain which may account for the tumoricidal
activity [6]. Although cell death machineries initiated by the
two frog oocyte-derived ribonucleases still remain unclear,
onconase is undergoing phase III clinical trials in the USA
as an anti-tumor drug [2,7].
Tumor-speci¢c cytotoxicity of RC-RNase has been reported
[8,9]. Using hepatocellular carcinoma cell lines with distinct
di¡erentiation stages, we established a rather simple correla-
tion between RC-RNase-induced cytotoxicity and cell di¡er-
entiation stage [9]. That is, RC-RNase-induced cytotoxicity
correlates with di¡erentiation given the evidence that RC-
RNase has a strong tumoricidal activity on poorly di¡erenti-
ated hepatoma cells, a lower activity on intermediately di¡er-
entiated ones, and a much lower activity on well-di¡erentiated
ones. RC-RNase is not cytotoxic to normal or immortalized
¢broblasts which both represent well-di¡erentiated cells. To
further strengthen the previous correlation hypothesis, we
wanted to conduct experiments in a cell system in which we
could actively induce di¡erentiation so that a clearer causal
relationship between RC-RNase-induced cytotoxicity and cell
di¡erentiation could be demonstrated.
Di¡erentiation of hematopoietic cells has been well studied.
For instance, undi¡erentiated human promyelocytic leukemic
HL-60 cells can be induced with several di¡erentiation-induc-
ing agents (e.g. dimethylsulfoxide (DMSO), retinoic acid, and
actinomycin D) which stimulate terminal di¡erentiation lead-
ing to the appearance of granulocyte-like characteristics as
judged by morphological and immunocytochemical means
[10^12]. This model has been used to investigate responses
of di¡erentiated and undi¡erentiated cells to cytotoxic agents
for years. By adopting this well-established hematopoietic dif-
ferentiation model, we aimed at establishing a causal relation-
ship between RC-RNase-induced cytotoxicity and cell di¡er-
entiation.
Initiation of the caspase-8/caspase-3 cascade is mediated by
ligands binding to death receptors (e.g. FasL/Fas) while acti-
vation of the caspase-9/caspase-3 cascade is induced by ho-
meostatic alterations in mitochondria [13^15]. Being highly
homologous to caspase-3 in amino acid sequence, caspase-7
also acts as an executioner protease. Both caspase-3 and -7
can induce cleavage of other procaspases and cellular sub-
strates such as poly(ADP-ribose) polymerase (PARP) [13].
In this study, we induced terminal di¡erentiation in HL-60
cells with DMSO and retinoic acid and showed that di¡er-
entiated HL-60 cells were much less susceptible to RC-RNase
than their undi¡erentiated counterparts. We also found that
RC-RNase can induce death in undi¡erentiated HL-60 cells
by activating the caspase-9/caspase-3 cascade and induction of
terminal di¡erentiation can reverse caspase activation and res-
cue the cells from death.
2. Materials and methods
2.1. Chemicals, cell lines, and culture conditions
All-trans-retinoic acid (RA), 12-O-tetradecanoylphorbol-13-acetate
(TPA) and nitroblue tetrazolium (NBT) were purchased from Sigma.
DMSO was bought from Merck. Caspase-3 monoclonal antibody and
caspase-9 monoclonal antibody were procured from Transduction
Laboratory and Upstate respectively. Actin monoclonal antibody
was purchased from Chemicon. Caspase-7 monoclonal antibody and
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PARP monoclonal antibody were bought from Biomol Research Lab-
oratories. Acetyl-Asp-Glu-Val-Asp-p-nitroanilide (Ac-DEVD-pNA)
and acetyl-Leu-Glu-His-Asp-p-nitroanilide (Ac-LEHD-pNA) were
procured from Anaspec. Human promyelocytic leukemia HL-60 cell
line was cultured in Dulbecco’s modi¢ed Eagle’s medium supple-
mented with 10% fetal bovine serum, 2 mM L-glutamine, 100 IU/ml
penicillin/streptomycin, 1 mM sodium pyruvate, and 0.1 mM non-
essential amino acids.
2.2. Puri¢cation of RC-RNase
The methods of RC-RNase puri¢cation from yolk granules in oo-
cytes of R. catesbeiana have been reported [5]. Brie£y, the soluble
fraction of crude yolk granule homogenate was obtained by centrifu-
gation and made to contain HEPES and EDTA to allow dross pre-
cipitation. Using a phosphocellulose column and then a carboxyme-
thylcellulose column, we puri¢ed RC-RNase. Ribonuclease activity
was con¢rmed by in situ RNA digestion in an RNA-cast sodium
dodecyl sulfate (SDS)-polyacrylamide gel and the dinucleotide CpG
cleavage assay as we have described before [5].
2.3. Induction of di¡erentiation
RA dissolved in 95% ethanol and DMSO were prepared. Cultured
HL-60 cells were treated with 1 WM RA or 1.3% DMSO in growth
medium for indicated days. All manipulations were performed under
subdued light.
2.4. NBT reduction assay
HL-60 cells were incubated with an equal volume of 0.2% NBT
containing 200 ng/ml TPA for 40 min at 37‡C. We could identify
di¡erentiated cells by their intracellular blue formazan deposits. A
minimum of 200 cells was counted under a light microscope for
each experiment.
2.5. Preparation of di¡erentiated HL-60 cells
HL-60 cells were induced to di¡erentiate into mature granulocytes
by RA or DMSO. The di¡erentiation percentage could be determined
by the NBT reduction assay. Di¡erentiated cells were then cultured in
fresh growth medium without RA or DMSO.
2.6. Cell viability assay
Cells were grown on 24-well cell culture plates overnight and then
treated with RC-RNase (2 Wg/ml or 20 Wg/ml in culture medium).
Every 24 h, trypan blue exclusion assays were performed and viable
cells were counted.
2.7. Western blotting
Cell lysates were obtained in RIPA bu¡er supplemented with pro-
tease inhibitors (cocktails from Calbiochem). Proteins in cell lysates
were run in a 13.3% SDS-polyacrylamide gel and transferred onto a
nitrocellulose membrane. Blocked with 5% non-fat milk in TBS-T
(0.8% NaCl, 0.02% KCl, 25 mM Tris^HCl, 0.05% Tween 20, pH
7.4), the membrane was reacted at 4‡C with primary antibodies
(1:500) overnight. Incubated with biotinylated anti-mouse IgG or
anti-rabbit IgG antibodies (1:2000), the membrane was subsequently
incubated with streptavidin^horseradish peroxidase conjugates
(1:4000). Labeled proteins were visualized by the Super Signal1
Chemiluminescent-HRP substrate system (Pierce, Rockford, IL,
USA).
2.8. Caspase activity assay
Cells were resuspended in lysis bu¡er (50 mM Tris^HCl, 120 mM
NaCl, 1 mM EDTA, 1% Nonidet P-40, pH 7.5) supplemented with
protease inhibitors. Cell lysates were obtained after centrifugation
(15 000Ug) for 20 min at 4‡C. Caspase activity assays were performed
as previously described [16]. In brief, the whole reaction contained 40
Wl cell lysates (80 Wg total protein), 158 Wl reaction bu¡er (20% glyc-
erol, 0.5 mM EDTA, 5 mM dithiothreitol, 100 mM HEPES, pH 7.5),
and 2 Wl £uorogenic Ac-DEVD-pNA or Ac-LEHD-pNA substrates
(100 WM ¢nal concentration). Samples were incubated for 6 h at 37‡C
and enzyme-catalyzed release of p-nitroanilide was monitored at 405
nm in an ultra-microplate reader (Bio-Tek instruments).
3. Results
3.1. Successful induction of di¡erentiation in HL-60 cells
The NBT reduction assay is a sensitive and easy method to
distinguish cell di¡erentiation. In the absence of inducers, un-
di¡erentiated HL-60 cells scarcely reduced NBT (Fig. 1A), but
the di¡erentiated HL-60 cells obtained from RA or DMSO
inductions could reduce NBT and generate blue-black forma-
zan (Fig. 1B,C). Formazan deposits were found in approxi-
mately 3^8% of undi¡erentiated HL-60 cells. After 7 days
incubation with 1 WM RA, more than 90% HL-60 cells di¡er-
entiated into mature granulocytes. There were approximately
80% HL-60 cells di¡erentiating into mature granulocytes after
8 days induction with 1.3% DMSO (Fig. 2A). Interestingly,
proliferation of HL-60 cells treated with RA or DMSO was
found to be signi¢cantly inhibited from day 6 (Fig. 2B). These
cells could no longer proliferate even when di¡erentiation in-
ducers were removed.
3.2. Di¡erentiated HL-60 cells were very resistant to
RC-RNase-induced cytotoxicity
Compared with undi¡erentiated cells (Fig. 3A), RA- or
DMSO-induced di¡erentiated cells were found to be much
less responsive to RC-RNase (Fig. 3B,C). As we have also
noted, RC-RNase-triggered cytotoxicity was concentration-
dependent in undi¡erentiated HL-60 cells (Fig. 3A). However,
the concentration-dependent relationships became much less
signi¢cant in di¡erentiated cells (Fig. 3B,C).
Fig. 1. Terminal di¡erentiation of HL-60 cells. NBT reduction assays were performed in unstimulated cells (A), cells treated with 1.3% DMSO
for 9 days (B), and cells treated with 1 WM RA for 7 days (C). Note NBT reduction-positive cells contain intracellular blue-black formazan de-
posits.
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3.3. Di¡erentiation rather than proliferation rescued HL-60
cells from RC-RNase-induced cytotoxicity
As we had observed in Fig. 2B, there was no proliferation
di¡erence between HL-60 cells treated with RA for 5 days and
those treated with RA for 7 days. However, approximately
70% of RA-treated cells were identi¢ed as di¡erentiated cells
on day 5 and approximately 90% of RA-treated cells on day 7
(Fig. 2A). Comparing the results from the two groups of cells
di¡erentiated with RA for 5 days and 7 days, we found RC-
RNase was less cytotoxic to cells di¡erentiated by RA for
7 days (Fig. 4A). This indicated that di¡erentiated cells be-
came less susceptible to RC-RNase treatments. Control ex-
periments in which the same two groups of di¡erentiated cells
were treated with H2O2 were conducted here to further dem-
onstrate that di¡erentiation-dependent cytotoxicity of RC-
RNase was not a common event (Fig. 4B).
3.4. RC-RNase-triggered caspase activation was modulated
by di¡erentiation in HL-60 cells
After undi¡erentiated HL-60 cells were treated with RC-
RNase (20 Wg/ml), procaspase-9, procaspase-3, and PARP
were cleaved time-dependently (Fig. 5A, lanes 1^3). The low-
est procaspase-9 and procaspase-3 levels were seen after treat-
ments with RC-RNase for 96 h. Cleavage of the intact PARP
(116 kDa) into the 89 kDa fragment was also found to be the
most evident after 96-h treatments with RC-RNase. No di¡er-
ence in caspase-7 activation was detectable even when proteol-
ysis of PARP had been so severe in cells stimulated with RC-
RNase for 96 h. Interestingly, in di¡erentiated HL-60 cells
obtained after 7 days induction with RA, cleavage of procas-
pase-3 and procaspase-9 was not detected after treatment with
Fig. 2. Di¡erentiation rate and growth curves of HL-60 cells after
treatments. Di¡erentiation rate after 9 days treatment with 1 WM
RA or 1.3% DMSO (A). Growth curves plotted for cells treated
with 1.3% DMSO or 1 WM RA (B). Each data point was obtained
from three triplicate groups and expressed as meanPS.D. Note
growth arrest for cells treated with DMSO or RA was signi¢cant
on day 6.
Fig. 3. The 5-day survival rates of undi¡erentiated and di¡erentiated
HL-60 cells. Di¡erentiated cells were obtained after treatment with
1 WM RA for 7 days or with 1.3% DMSO for 9 days. Indicated
concentrations of RC-RNase were used to stimulate undi¡erentiated
cells (A) and di¡erentiated cells from RA treatment (B) or DMSO
treatment (C). Each data point was calculated from three quadrupli-
cate groups and expressed as meanPS.D. Note RC-RNase was
much less cytotoxic to di¡erentiated cells.
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RC-RNase for 48 h or 96 h (Fig. 5A, lanes 4^6). PARP,
known as the best characterized proteolytic substrate for cas-
pases, also was hardly cleaved in these di¡erentiated HL-60
cells after RC-RNase treatments. To further demonstrate that
caspase-3 and caspase-9 were less activated in di¡erentiated
HL-60 cells after RC-RNase treatments, we adopted substrate
cleavage assays in which cell lysates were incubated with £uo-
rogenic Ac-DEVD-pNA or Ac-LEHD-pNA. There were
much lower caspase-3 activity and much lower caspase-9 ac-
tivity in di¡erentiated HL-60 cells (from 7 days induction with
RA) than in undi¡erentiated HL-60 cells no matter which
RC-RNase treatment groups (48 h or 96 h) were compared
(Fig. 5B,C).
4. Discussion
HL-60 cells provide a convenient system for studying di¡er-
entiation. HL-60 cells can be induced to di¡erentiate into
macrophage-like, monocyte-like, or granulocyte-like charac-
teristics by di¡erent inducing chemicals and di¡erent culture
conditions [10^12,17]. In this study, we induced HL-60 cells to
di¡erentiate into mature granulocytes by using DMSO or RA.
Compared with DMSO, RA had higher di¡erentiation-induc-
Fig. 4. Di¡erentiation-dependent cytotoxicity of RC-RNase. HL-60
cells di¡erentiated with RA for 5 days or 7 days were treated with
RC-RNase (20 Wg/ml). The 5-day survival rates for the two groups
of cells were plotted from data points calculated from three quadru-
plicate experiments and shown as meanPS.D. (A). Treating the
same two groups of di¡erentiated HL-60 cells with 50 WM H2O2
was used as control and the data points were also calculated from
three quadruplicate experiments and expressed as meanPS.D. (B).
Note cytotoxicity triggered by H2O2 was not di¡erentiation-depen-
dent.
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Fig. 5. RC-RNase-induced caspase activation was modulated by dif-
ferentiation. Cleavage of procaspases and PARP was analyzed by
Western blotting (A). Undi¡erentiated HL-60 cells were treated with
RC-RNase (20 Wg/ml) for 0 h (lane 1), 48 h (lane 2), or 96 h (lane
3); di¡erentiated HL-60 cells obtained from 7 days induction by
RA were treated with RC-RNase for 0 h (lane 4), 48 h (lane 5), or
96 h (lane 6). Detection of actin served as internal control. Note
cleavage of procaspase-3, procaspase-9, and PARP was only seen in
undi¡erentiated HL-60 cells treated with RC-RNase. Caspase-3 ac-
tivity (B) and caspase-9 activity (C) were determined in undi¡erenti-
ated HL-60 cells and di¡erentiated HL-60 cells (7 days induction by
RA) after these cells were treated with RC-RNase (20 Wg/ml) for
48 h or 96 h. Bars represented meanPS.D. from three independent
triplicate experiments.
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ing activities to HL-60 cells. We also found HL-60 cells grad-
ually died after treatment with RA or DMSO for 2 weeks.
Therefore, to avoid cytotoxicity from RA or DMSO, we care-
fully removed RA or DMSO before conducting experiments
on di¡erentiated HL-60 cells.
Most malignant tumor cells are highly proliferative and
poorly di¡erentiated. Previous studies have demonstrated
that RC-RNase can kill a series of malignant cells, but not
normal cells [8,9]. On the basis of a nice correlation, we hy-
pothesized that RC-RNase exerted di¡erent cytotoxicity on
distinct hepatoma cell lines according to the di¡erentiation
stage of the cell lines [9]. Onconase, homologous to RC-
RNase, has been reported to induce tumor cell death and its
cytotoxicity has been reported to associate with proliferation
[18]. To further demonstrate a causal relationship between cell
di¡erentiation and RC-RNase-induced cytotoxicity, we com-
pared survival rates of the RC-RNase-treated HL-60 cells that
were di¡erentiated by RA for 5 days or 7 days prior to RC-
RNase treatments. As we have seen, the two groups of cells
no longer proliferated (Fig. 2B) and were still able to resist
RC-RNase-induced cell death (Figs. 3B and 4A). Cells di¡er-
entiated by RA for 7 days were much more resistant to RC-
RNase treatments than those di¡erentiated by RA for 5 days.
There was approximately 17.5% di¡erence between the surviv-
al rates of the two groups of cells after 5 days induction with
RC-RNase (Fig. 4A). Therefore, in terms of di¡erentiation
and proliferation, di¡erentiation seemed to be a signi¢cant
factor that decided susceptibility of the cells to RC-RNase-
induced cytotoxicity. Since RC-RNase is only found in the
oocytic and embryonic stages of bullfrog development [19]
and was shown to be much more cytotoxic to undi¡erentiated
or poorly di¡erentiated cells, we thought RC-RNase might
play a role in di¡erentiation regulation during bullfrog em-
bryogenesis.
It has been reported that onconase induced activation of
the caspase-9/-3 cascade [20]. Here we reported activation of
the same cascade in undi¡erentiated HL-60 cells after RC-
RNase treatments. However, morphological characteristics
of apoptosis such as chromosome condensation were not ap-
parent in HL-60 cells after RC-RNase treatments (data not
shown) and the data were congruent with the ¢ndings in RC-
RNase-treated hepatoma cells [9]. Dye penetration was seen in
some of the cells treated with RC-RNase for 5 days indicating
that these cells began to undergo necrosis. Cytotoxicity of
RC-RNase has been shown to relate to mitochondrial disrup-
tions [5,9] and here we demonstrated RC-RNase could initiate
the mitochondrial death pathway. Comparing our results with
the mitochondrial death pathway triggered by H2O2 in HL-60
cells [21,22], we found ZVAD (a caspase inhibitor) rescued
HL-60 cells from H2O2-induced death but not RC-RNase-
induced death (data not shown). Along with previous studies
showing that apoptotic and necrotic features were not ob-
served in RC-RNase-treated hepatoma cells [9] and that ex-
ecutioner caspase-7 was activated in RC-RNase-treated MCF-
7 cells even when there was no activation of initiator caspase-
8 or -9 [5], we therefore proposed that RC-RNase might in-
duce cell death through multiple pathways. Due to genetic
heterogeneities of di¡erent cell lines, RC-RNase might trigger
disparate caspase activation cascades in di¡erent cell lines.
In the present study, activation of the caspase-9/-3 cascade
was seen in RC-RNase-treated undi¡erentiated HL-60 cells
even though some of the cells were observed to be necrotic
after longer RC-RNase treatments. The Fas (CD95) receptor
is known to be upregulated by RA or DMSO [23]. Our data
showing RC-RNase was much less toxic to cells pretreated
with RA or DMSO clearly demonstrated that RC-RNase
did not induce death by binding to the Fas death receptor
or by activating the FasL/Fas death receptor.
Many morphological and functional changes have been re-
ported in di¡erentiated HL-60 cells, including generation of
superoxide [24], reassembly of the cytoskeleton [25], decrease
of RNA synthesis [26,27], formation of chromatin sheets [28],
and alterations of enzyme metabolism [29,30]. These changes
might be the reason why di¡erentiated HL-60 cells became
resistant to RC-RNase. Since RC-RNase preferred to degrade
ribosomal RNA [8] and the ribonuclease activity of RC-
RNase was closely related to its cytotoxicity [31], a decrease
of RNA synthesis in di¡erentiated HL-60 cells could be a
reason why di¡erentiated HL-60 cells could be more resistant
to RC-RNase treatments. As we have shown here, di¡erenti-
ated HL-60 cells acted against RC-RNase-induced cytotoxic-
ity by placing a curb on the activation of the caspase-9/-3
cascade (Fig. 5). We thought that there might be some anti-
apoptotic proteins upregulated in the di¡erentiated HL-60
cells and these proteins inhibited cleavage of procaspase-9
and procaspase-3 and rescued cells from death.
In conclusion, this is the ¢rst report directly demonstrating
that di¡erentiation is a signi¢cant factor to account for the
selective tumoricidal e¡ects of RC-RNase.
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